Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway

Microvascular Research

Volumn 89, Issue , 2013, Pages 15-24

  Mammoto, Tadanori ^a,b   Jiang, Amanda ^a,b   Jiang, Elisabeth ^a,b   Mammoto, Akiko ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; FIBRIN; HEMATOLOGIC AGENT; PLATELET DERIVED GROWTH FACTOR BB; PLATELET RICH PLASMA EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RETINA ARTERY; SIGNAL TRANSDUCTION; SKIN CELL; THROMBOCYTE;

3D; ACUTE RESPIRATORY DISTRESS SYNDROME; ANG; ANGIOPOIETIN; ARDS; B-FGF; BASIC FIBROBLAST GROWTH FACTOR; BRDU; BROMODEOXYURIDINE; CONA; CONCANAVALIN-A; D-HMVE; EBM2; EC; ECM; ELISA; ENDOTHELIAL BASAL MEDIUM-2; ENDOTHELIAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FDA; FOOD AND DRUG ADMINISTRATION; H&E; HEMATOXYLIN AND EOSIN; HUMAN DERMAL MICROVASCULAR ENDOTHELIAL; IF; IMMUNOFLUORESCENCE; INTRAPERITONEAL; IP; PD-EGF; PDGF; PDMS; PLATELET RICH FIBRIN; PLATELET RICH PLASMA; PLATELET-DERIVED EPIDERMAL GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR; POLYDIMETHYLSILOXANE; PRF; PRP; QRT-PCR; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TGF-Β; THREE DIMENSIONAL; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; VEGF; VEGFR2;

ANGIOPOIETIN-1; ANIMALS; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-RICH PLASMA; RECEPTOR, TIE-2; REGENERATION; RETINA; RETINAL VESSELS; RNA INTERFERENCE;

EID: 84883172376     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.04.008     Document Type: Article

References (78)

1. Augustin H.G., et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 2009, 10:165-177.
2. Banai S., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994, 89:2183-2189.
3. Barrientos S., et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008, 16:585-601.
4. Borzini P., Mazzucco L. Platelet gels and releasates. Curr. Opin. Hematol. 2005, 12:473-479.
5. Butler J.M., et al. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat. Rev. Cancer 2010, 10:138-146.
6. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
7. Carmeliet P., Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005, 436:193-200.
8. Choukroun J., et al. Une opportunité en paro-implantologie: le PRF. Implantodontie 2001, 42:55-62.
9. Chung A.S., Ferrara N. Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 2011, 27:563-584.
10. Connor K.M., et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 2009, 4:1565-1573.
11. Coppinger J.A., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103:2096-2104.
12. Crivellato E. The role of angiogenic growth factors in organogenesis. Int. J. Dev. Biol. 2011, 55:365-375.
13. Crivellato E., et al. Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept. J. Anat. 2007, 211:415-427.
14. Das A., et al. Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization. Lab. Invest. 2003, 83:1637-1645.
15. Demidova-Rice T.N., et al. Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS One 2012, 7:e32146.
16. Ding B.S., et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010, 468:310-315.
17. Ding B.S., et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 2011, 147:539-553.
18. Dohan Ehrenfest D.M., et al. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009, 27:158-167.
19. Dohan D.M., et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006, 101:e51-e55.
20. Emanueli C., Madeddu P. Changing the logic of therapeutic angiogenesis for ischemic disease. Trends Mol. Med. 2005, 11:207-216.
21. Everts P.A., et al. Platelet-rich plasma and platelet gel: a review. J. Extra Corpor. Technol. 2006, 38:174-187.
22. Foster T.E., et al. Platelet-rich plasma: from basic science to clinical applications. Am. J. Sports Med. 2009, 37:2259-2272.
23. Fukuhara S., et al. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol. Histopathol. 2010, 25:387-396.
24. Hammond J.W., et al. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am. J. Sports Med. 2009, 37:1135-1142.
25. Hanel P., et al. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 2007, 21:1202-1209.
26. Heinke J., et al. Life is a pattern: vascular assembly within the embryo. Front. Biosci. (Elite Ed.) 2012, 4:2269-2288.
27. Herbert S.P., Stainier D.Y. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat. Rev. Mol. Cell Biol. 2011, 12:551-564.
28. Huang Y.Q., et al. Identification of a family of alternatively spliced mRNA species of angiopoietin-1. Blood 2000, 95:1993-1999.
29. Italiano J.E., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008, 111:1227-1233.
30. Jeansson M., et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 2011, 121:2278-2289.
31. Joussen A.M., et al. Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol. 2002, 160:1683-1693.
32. Jung B., et al. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. Dev. Cell 2012, 23:600-610.
33. Jurk K., Kehrel B.E. Platelets: physiology and biochemistry. Semin. Thromb. Hemost. 2005, 31:381-392.
34. Kisucka J., et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:855-860.
35. Klement G.L., et al. Platelets actively sequester angiogenesis regulators. Blood 2009, 113:2835-2842.
36. Koch S., Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb. Perspect. Med. 2012, 2:a006502.
37. Koh G.Y. Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol. Med. 2013, 19:31-39.
38. Kurita J., et al. Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel. Ann. Thorac. Surg. 2011, 92:837-844. (discussion 844).
39. Lamalice L., et al. Endothelial cell migration during angiogenesis. Circ. Res. 2007, 100:782-794.
40. Li J.J., et al. Thrombin induces the release of angiopoietin-1 from platelets. Thromb. Haemost. 2001, 85:204-206.
41. Lucarelli E., et al. A recently developed bifacial platelet-rich fibrin matrix. Eur. Cell. Mater. 2010, 20:13-23.
42. Luo J., et al. VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications. J. Mol. Med. (Berl.) 2011, 89:635-645.
43. Mammoto A., et al. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J. Biol. Chem. 2004, 279:26323-26330.
44. Mammoto T., et al. Angiopoietin-1 requires p190RhoGAP to protect against vascular leakage in vivo. J. Biol. Chem. 2007, 282:23910-23918.
45. Mammoto A., et al. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009, 457:1103-1108.
46. Mammoto A., et al. Mechanosensitive mechanisms in transcriptional regulation. J. Cell Sci. 2012, 125:3061-3073.
47. Mammoto T., et al. LRP5 regulates development of lung microvessels and alveoli through the angiopoietin-Tie2 pathway. PLoS One 2012, 7:e41596.
48. Matsumoto K., et al. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001, 294:559-563.
49. McNicol A., Israels S.J. Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc. Hematol. Disord. Drug Targets 2008, 8:99-117.
50. Mooren R.E., et al. The effect of platelet-rich plasma in vitro on primary cells: rat osteoblast-like cells and human endothelial cells. Tissue Eng. Part A 2010, 16:3159-3172.
51. Nachman R.L., Rafii S. Platelets, petechiae, and preservation of the vascular wall. N. Engl. J. Med. 2008, 359:1261-1270.
52. Navaratna D., et al. Mechanisms and targets for angiogenic therapy after stroke. Cell Adh. Migr. 2009, 3:216-223.
53. Nucera S., et al. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int. J. Dev. Biol. 2011, 55:495-503.
54. Parikh S.M., et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006, 3:e46.
55. Patel J.I., et al. Angiopoietin concentrations in diabetic retinopathy. Br. J. Ophthalmol. 2005, 89:480-483.
56. Patzelt J., Langer H.F. Platelets in angiogenesis. Curr. Vasc. Pharmacol. 2012, 10:570-577.
57. Pfister F., et al. Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol. 2010, 47:59-64.
58. Pinedo H.M., et al. Involvement of platelets in tumour angiogenesis?. Lancet 1998, 352:1775-1777.
59. Pintucci G., et al. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb. Haemost. 2002, 88:834-842.
60. Post S., et al. Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J. Vasc. Res. 2008, 45:244-250.
61. Reheman A., et al. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood 2009, 113:1809-1817.
62. Roy S., et al. Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Wound Repair Regen. 2011, 19:753-766.
63. Saharinen P., et al. How do angiopoietins tie in with vascular endothelial growth factors?. Curr. Opin. Hematol. 2010, 17:198-205.
64. Sakaguchi T.F., et al. Endothelial signals modulate hepatocyte apicobasal polarization in zebrafish. Curr. Biol. 2008, 18:1565-1571.
65. Sanchez-Gonzalez D.J., et al. Platelet-rich plasma peptides: key for regeneration. Int. J. Pept. 2012, 2012:532519.
66. Sato T.N., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74.
67. Sato T., et al. Vitreous levels of angiopoietin-1 and angiopoietin-2 in eyes with retinopathy of prematurity. Am. J. Ophthalmol. 2011, 151:353-357. (e1).
68. Stahl A., et al. The mouse retina as an angiogenesis model. Invest. Ophthalmol. Vis. Sci. 2010, 51:2813-2826.
69. Suri C., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
70. Suri C., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282:468-471.
71. Takeshita S., et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 1994, 93:662-670.
72. Voelkel N.F., et al. Angiogenesis in chronic lung disease. Chest 2007, 131:874-879.
73. Wang B., et al. Targeted delivery of VEGF to treat myocardial infarction. Adv. Exp. Med. Biol. 2013, 765:307-314.
74. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
75. Weyrich A.S., et al. Protein synthesis by platelets: historical and new perspectives. J. Thromb. Haemost. 2009, 7:241-246.
76. Xu Y., et al. Activated platelets contribute importantly to myocardial reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H692-H699.
77. Yancopoulos G.D., et al. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
78. Zhou B., et al. Therapeutic neovascularization for peripheral arterial diseases: advances and perspectives. Histol. Histopathol. 2007, 22:677-686.